|
Volumn 137, Issue 3, 2007, Pages
|
Probiotic bacteria: Legislative framework - Requirements to evidence basis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
PLACEBO;
PROBIOTIC AGENT;
ANTIBIOTIC THERAPY;
ARTIFICIAL MILK;
BIFIDOBACTERIACEAE;
CLINICAL TRIAL;
CLOSTRIDIUM DIFFICILE;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DIARRHEA;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
HEALTH CARE ORGANIZATION;
HUMAN;
LACTIC ACID BACTERIUM;
LACTOBACILLUS;
LACTOBACILLUS RHAMNOSUS;
NONHUMAN;
NUTRITIONAL ASSESSMENT;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
WORLD HEALTH ORGANIZATION;
|
EID: 33947147177
PISSN: 00223166
EISSN: 15416100
Source Type: Journal
DOI: 10.1093/jn/137.3.850s Document Type: Conference Paper |
Times cited : (194)
|
References (3)
|